Comparison of the abbott 7000 and bayer 340 systems for measurement of hepatitis C virus load
- PMID: 17596352
- PMCID: PMC2045268
- DOI: 10.1128/JCM.00202-07
Comparison of the abbott 7000 and bayer 340 systems for measurement of hepatitis C virus load
Abstract
This study compared two commercially available assays for the measurement of hepatitis C virus (HCV) RNA levels, the Bayer HCV RNA (version 3.0) branched DNA assay and the Abbott HCV analyte-specific reagent real-time PCR assay, to assess their quantitative relationships, ease of performance, and time to completion. The study group consisted of randomly selected patients from the NIAID human immunodeficiency virus (HIV) outpatient clinic who were infected with HIV type 1 and HCV. One hundred eighty-four samples from 66 patients coinfected with HIV and HCV receiving treatments under various protocols were analyzed for the correlation and agreement of the results. The results indicated that the two assays correlate well in the overlapping linear ranges of the assays and show good agreement. From the results obtained, we have derived a mathematical formula to compare the viral load results between the two assays, which is given as log(10) Abbott assay measure = 0.032 + 1.01 log(10) Bayer assay measure. Although it is preferable to use the same quantitation assay throughout the course of a patient's treatment, valid comparisons of the HCV RNA levels may be made between the results obtained by either of these assays in the overlapping linear range (615 to 7,700,000 IU/ml).
Figures


Similar articles
-
Multilaboratory comparison of hepatitis C virus viral load assays.J Clin Microbiol. 2006 May;44(5):1726-32. doi: 10.1128/JCM.44.5.1726-1732.2006. J Clin Microbiol. 2006. PMID: 16672399 Free PMC article.
-
Evaluation of the Abbott investigational use only RealTime hepatitis C virus (HCV) assay and comparison to the Roche TaqMan HCV analyte-specific reagent assay.J Clin Microbiol. 2009 Sep;47(9):2872-8. doi: 10.1128/JCM.02329-08. Epub 2009 Jul 22. J Clin Microbiol. 2009. PMID: 19625475 Free PMC article.
-
Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples?J Virol Methods. 2012 Apr;181(1):131-3. doi: 10.1016/j.jviromet.2012.01.006. Epub 2012 Jan 20. J Virol Methods. 2012. PMID: 22285372
-
Comparison of the Abbott Realtime HIV-1 and HCV viral load assays with commercial competitor assays.Expert Rev Mol Diagn. 2008 Jul;8(4):369-77. doi: 10.1586/14737159.8.4.369. Expert Rev Mol Diagn. 2008. PMID: 18598219 Review.
-
Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysis.Lancet Gastroenterol Hepatol. 2023 Mar;8(3):253-270. doi: 10.1016/S2468-1253(22)00346-6. Epub 2023 Jan 24. Lancet Gastroenterol Hepatol. 2023. PMID: 36706775 Free PMC article.
Cited by
-
Within-Cluster Resampling for Analysis of Family Data: Ready for Prime-Time?Stat Interface. 2010 Apr 1;3(2):169-176. doi: 10.4310/sii.2010.v3.n2.a4. Stat Interface. 2010. PMID: 20664749 Free PMC article.
-
A novel diagnostic target in the hepatitis C virus genome.PLoS Med. 2009 Feb 10;6(2):e31. doi: 10.1371/journal.pmed.1000031. PLoS Med. 2009. PMID: 19209955 Free PMC article.
References
-
- Alter, M. J., H. S. Margolis, K. Krawczynski, F. N. Judson, A. Mares, W. J. Alexander, P. Y. Hu, J. K. Miller, M. A. Gerber, R. E. Sampliner, et al. 1992. The natural history of community-acquired hepatitis C in the United States. N. Engl. J. Med. 327:1899-1905. - PubMed
-
- Benhamou, Y., M. Bochet, V. Di Martino, F. Charlotte, F. Azria, A. Coutellier, M. Vidaud, F. Bricaire, P. Opolon, C. Katlama, T. Poynard, et al. 1999. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 30:1054-1058. - PubMed
-
- Bland, J. M., and D. G. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307-310. - PubMed
-
- Chung, R. T., J. Andersen, P. Volberding, G. K. Robbins, T. Liu, K. E. Sherman, M. G. Peters, M. J. Koziel, A. K. Bhan, B. Alston, D. Colquhoun, T. Nevin, G. Harb, and C. van der Horst. 2004. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N. Engl. J. Med. 351:451-459. - PMC - PubMed
-
- Elbeik, T., N. Markowitz, P. Nassos, U. Kumar, S. Beringer, B. Haller, and V. Ng. 2004. Simultaneous runs of the Bayer VERSANT HIV-1 version 3.0 and HCV bDNA version 3.0 quantitative assays on the system 340 platform provide reliable quantitation and improved work flow. J. Clin. Microbiol. 42:3120-3127. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical